Contact Information: Contact: Stephanie Marks for Insulet Corporation 877-PODD-IR1 (877-763-3471)
Insulet Corporation to Report Fourth Quarter and Full Year 2009 Financial Results on Tuesday, February 9, 2010
| Source: Insulet Corporation
BEDFORD, MA--(Marketwire - February 1, 2010) - Insulet Corporation (NASDAQ : PODD ), the leader
in tubing-free insulin pump technology with its OmniPod® Insulin
Management System announced plans to release its financial results for the
fourth quarter and full year 2009 on Tuesday, February 9, 2010 after the
close of the financial markets.
Insulet will also host a conference call at 5:00 p.m. Eastern Time on
Tuesday, February 9, 2010 to discuss its fourth quarter and full year 2009
financial results. During the conference call, material information
concerning the Company, its operations, strategies and prospects may be
discussed.
To listen to the conference call, please dial 800-901-5218 for domestic
callers and 617-786-4511 for international callers. The passcode is
78048665. A replay of the conference call will be available two hours after
the start of the call through February 16, 2010 by dialing 888-286-8010
(domestic) and 617-801-6888 (international), passcode 95682410. An online
archive of the conference call will also be available by accessing the
Investor Information section of the company's website at
http://investors.insulet.com.
About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated to
improving the lives of people with diabetes. The Company's OmniPod Insulin
Management System is a revolutionary, discreet and easy-to-use insulin
infusion system that features two easy-to-use parts with no tubing and
fully-automated cannula insertion. Through the OmniPod System, Insulet
seeks to expand the use of continuous subcutaneous insulin infusion (CSII)
therapy among people with insulin-dependent diabetes. Founded in 2000,
Insulet is based in Bedford, MA